Numb To It All.

Numb To It All.

Markets seem generally numb to it all by now, but news flow surrounding America’s ongoing COVID-19 epidemic deteriorated further on Thursday.

Florida reported a record number of new deaths (156), Colorado issued a statewide mask mandate, California logged 118 fatalities, and New York announced more stringent punishments for violations of containment measures at restaurants and bars, with governor Andrew Cuomo threatening to close businesses deemed repeat offenders and yank liquor licenses from establishments committing “egregious” violations.

Just another day in the only developed country on the planet which hasn’t managed to flatten its virus curves, despite possessing unlimited financial resources.

Speaking of unlimited financial resources, Nancy Pelosi told Bloomberg on Thursday she’s confident that Senate Republicans will ultimately deliver a new relief package.

“I have no doubt they’ll come around”, she said, noting that there is no longer a debate about whether more stimulus is necessary. The only question now is around the size of the bill.

The latest jobless claims data showed the US labor market is far from healed, and as long as the re-opening push is paused (or going in reverse) in some states, the pace of improvement is likely to be sluggish, at best.

“The jobs market remains a worry. The total number of people claiming benefits under all programs, while falling, is still up at 32 million”, ING’s James Knightley remarked, adding that “this only serves to illustrate ongoing extreme stress and suggests unemployment is closer to 20% than the 11.1% currently listed as the ‘official’ rate”.

Some dispute that interpretation, but the overarching point is that we are a long way from a healthy labor market — there’s no disputing that.

As such, the prospect of allowing extra federal unemployment benefits to expire with millions still filing each week seems like a non-starter.

The disconcerting claims figures overwhelmed another beat on retail sales in investors’ minds on Thursday. That underscores the notion that with new lockdowns and various restrictions going into effect in real time, only the most current data matters. Or at least to traders.

“Despite another day of better- than-expected data in consumption, manufacturing, and housing, the Treasury curve bull flattened as investors look through the majority of statistical releases, preferring instead to focus on either higher-frequency indicators or forward-looking metrics”, BMO’s Jon Hill and Ian Lyngen wrote in a late afternoon note, referencing the emphasis investors put on the claims numbers.

“Eventually, the regime will shift to one where economic fundamentals carry significant weight for price discovery [but] for that to occur, we’ll need to have pivoted to more of a steady-state whereby the (recent) past is informative for the future”, they went on to say, before noting that because “July brought re-lockdowns in parts of the US, that’s not the current story”.

This also explains why vaccine headlines serve as a powerful catalyst for risk sentiment, while macro data referencing what happened last month is viewed as past its expiration date. Unfortunately, this dynamic only works for good data — that is, any disappointments are likely to be viewed as aggravating factors, while upside surprises will be cast aside as “stale”. This will persist until virus curves flatten, concrete progress on vaccines/therapeutics is announced, or, ideally, both.

In a break with the normal interaction between rates, the re-opening narrative, and which styles and sectors lead/lag in equities land, big-cap tech has underperformed handily, trailing the S&P by the most since February of 2016.

The spread between the Nasdaq’s “fear gauge” and the VIX hit the highest in a decade and a half this week, after plummeting during the crisis as tech outperformed.

The dollar rose in the US afternoon after touching the lowest in five weeks. “US equities ran out of steam again, concerns about the virus and US/Chinese relations hurt and risk is back ‘off'”, SocGen’s Kit Juckes wrote. “Bond yields are depressed, and the dollar is the pick of the major currencies today”.

Overall, the S&P is still on track to log a third weekly gain.

For their part, Morgan Stanley remains upbeat on the outlook despite the disconcerting virus headlines. “While several states have chosen to delay or have partially reversed their reopening plans, these actions have had a relatively small impact on the pace of the recovery so far”, the bank said, in a note out this week.

“The variety of high frequency indicators that we track have bounced back strongly in June as compared with May [and] based on the data at hand for the first two weeks of July, they have continued to gather further momentum”, the same update reads.

Still, Morgan concedes that “if new cases, especially in the hotspots of large states like Florida, Texas and California, do not settle in the near term with the current set of measures, tighter restrictions are in the cards”.

Although the bank’s tone is overtly constructive in keeping with their house view for a “V-shaped” recovery, Chetan Ahya does caution that “the risk of a strict lockdown will re-emerge if the number of new cases nationwide does not settle by the end of September [and] that may strain hospital capacity when the normal flu season starts and tends to accelerate from mid-November onwards”.

After the bell on Wall Street, Netflix plunged as the company’s subscriber forecast and revenue outlook trailed estimates.


7 thoughts on “Numb To It All.

  1. For what it’s worth to the macro picture, each day brings more Fall school closures here in California (i.e. online school at home only). The 4 largest cities have done this, and most major suburban areas are following suit, one by one.

    Based on my own situation and anecdotally from friends, family and acquaintances, this will result in economic drag.

    Seems like other states with virus spread issues have a challenging decision to make: Close schools and take the hit, or leave them open, watch spread accelerate further in the Fall, then take the hit with a sick population and forced stay-at-home measures.

  2. Yeah but we have all this de-regulation……………

    Folks, this is not going to stop without drastic measures (lockdowns). Yes, mask compliance combined with washing, distancing etc will slow but there is too much virus out there almost everywhere.

    If schools open they will close again if virus is not greatly reduced.

    Oh, and assuming we get a good vaccine it will only help late 2021 into 2022. A lot of bankruptcies, houses lost, write-offs, lower spending, jobs, investment in the meantime.

    I will be greatly (and wonderfully) surprised if this scenario is not how it plays out. I hope I am wrong but fear I am right.

    Govt spending will explode higher and Fed will be buying everything by early 2021 through early 2023 imo.

    Most people have no clue how bad this will probably get. Don’t pick up nickels or play the greater fool game. Wait for a fat pitch. Better opportunities are probably coming.

    In the meantime stay safe as your health is the greatest asset of all!!

  3. Not sure why their is such optimism over a vaccine. Even if we assume a viable vaccine will be approved by the end of the year, what can we expect after that?

    Well, if the PPE and testing boondoggle are any guide, then we should expect vaccines to flow freely among the White House, Congress, NBA, NFL and Hollywood, while the rest of us wait weeks or months for them to trickle down, even then requiring us to drive long distances and wait in long lines for the privilege.

    And even if/when general availability of vaccine arrives, given what we are currently witnessing in refusing to weak masks as am existential risk to life as we know it, I would expect that the anti-vaccine crowd will surge to unprecedented numbers.

    Limited, controlled availability + freedom to be me + Trump fudge factor = no panacea.

Speak your mind

This site uses Akismet to reduce spam. Learn how your comment data is processed.